Skip to content

Gait analysis after joint replacement

Gait analysis after joint replacement

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078622
Enrollment
Unknown
Registered
2023-12-14
Start date
2023-12-15
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

total hip arthroplasty,THA:none
total knee arthroplasty,TKA:none
unicompartmental knee arthroplasty,UKA:none

Sponsors

The Fourth Medical Centre, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients aged 18-80 years (including boundary values), except pregnant women; (2) Patients requiring hip replacement or knee replacement or single condylar replacement; (3) Patients voluntarily participate in clinical trials and are willing to sign informed consent.

Exclusion criteria

Exclusion criteria: (1) BMI > 40; (2) Patients with neuromuscular dysfunction (e.g., paralysis, myolysis, or abductor weakness) resulting in hip instability or gait abnormalities after surgery; (3) Patients with a history of infection or existing suspected/confirmed infection of the hip or knee or other parts of the body; (4) Patients with sepsis or osteomyelitis; (5) Patients with ankylosing spondylitis with bone rigidity or severe rigidity; (6) The patient is known to have a history of allergy to one or more implanted materials; (7) Patients with primary or metastatic tumors or related history; (8) Patients whose hip or knee joint has been fused for a long time without pain and deformity; (9) Patients expected to have poor compliance; (10) Pregnant or lactating women, or patients who have a family plan during the clinical study; (11) The patient had participated in other drug clinical trials within 3 months before enrollment, or had participated in other device clinical trials within 1 month before enrollment; (12) Other situations in which the investigator considers it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
Gait analysis;

Secondary

MeasureTime frame
Harris ;Western Ontario and McMaster University Osteoarthritis Index (WOMAC) ;visual analogue scale(VAS);

Countries

China

Contacts

Public ContactWei Chain,Xiang Li

The Fourth Medical Centre, Chinese PLA General Hospital

henan12890@163.com+86 137 1680 9542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026